Dr. Hensing is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2650 Ridge Ave
Div. Of Hematology-Oncology
Evanston, IL 60201Phone+1 888-909-5222Fax+1 847-570-2336
Education & Training
Northwestern UniversityMS, Healthcare Quality and Patient Safety, 2015 - 2017
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 1997 - 1999- University of North Carolina HospitalsResidency, Internal Medicine, 1994 - 1997
University of Maryland School of MedicineClass of 1994
Certifications & Licensure
IL State Medical License 2003 - 2026
NC State Medical License 1996 - 2003- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2012 Sep 28
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsGermline mutations in high penetrance genes are associated with worse clinical outcomes in patients with non-small cell lung cancer.Seth B Krantz, Kanwal Zeeshan, Kristine M Kuchta, Thomas A Hensing, Kathy A Mangold
JTCVS Open. 2022-12-01 - 2 citationsSafe Transitions and Congregate Living in the Age of COVID-19: A Retrospective Cohort Study.Christopher A Boyle, Urmila Ravichandran, Valerie Hankamp, Nadim M. Ilbawi, Coleen Conway-Svec
Journal of Hospital Medicine. 2021-08-18 - Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients W...Thomas A. Hensing, Xiaofei Wang, Thomas E. Stinchcombe, Junheng Gao, Michael V. Knopp
JTO Clinical and Research Reports. 2021-08-01
Press Mentions
Advancing Stage III NSCLC Care Requires Personalized, Multidisciplinary ApproachOctober 5th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
